In September 2019 the International Equestrian Federation (FEI) has reported an anti-doping rule violation against the Czech jumping rider Emma Augier de Moussac after her sample tested positive for the prohibited substance Hydrochlorothiazide. After notification the Athlete gave a prompt admission, accepted a provisional suspension and the sanction proposed by FEI.
The parties in this case reached an agreement and requested the FEI Tribunal to issue a Decision incorporating the terms of this agreement. The parties agreed that the violation was not intentional and the result of the Athlete’s use of contaminated supplement for weight loss while there are grounds for No Significant Fault or Negligence.
The Panel considers that the violation was not intentional, that the Athlete gave a prompt admission, explained how the prohibited substance entered her system and established grounds for No Significant Fault or Negligence.
Therefore the FEI Tribunal decides on 16 June 2020 in accordance with the mutual consent of the Parties to impose a fine and a 12 month period of ineligibility on the Athlete starting on the date of the sample collection, i.e. on 28 June 2019.
